Oviductus ranae (OR) is a traditional Chinese medicine, which was first recorded in the Compendium of Materia Medica in the Ming Dynasty. OR contains high amounts of proteins and elicits therapeutic effects on neurasthenia, insomnia, and respiratory symptoms, which are related to oxidative stress and immunodeficiency. This study aimed to obtain the potential of OR for the development of functional food possessing antioxidant and immune-enhancement functions in the same dose. In antioxidant evaluation, OR can significantly decrease malondialdehyde and protein carbonyls (P < 0.05, P < 0.01) and significantly increase total superoxide dismutase and glutathione in a dose-dependent manner (P < 0.05, P < 0.01) against ethanol-induced oxidative stress in mice at 0.1, 1.0, and 3.0 g/kg BW. In immunomodulatory evaluation, OR could significantly enhance the phagocytosis of liver macrophages (P < 0.05, P < 0.01), delayed-type hypersensitivity response (P < 0.05, P < 0.01), hemolytic activity (P < 0.05), antibody-producing cells (P < 0.05), and natural killer cell activity (P < 0.05) in the same dose range described in antioxidant evaluation compared with those in the normal control. OR slightly influenced lymphocyte proliferation, peritoneal macrophage phagocytosis, and immune organ indices in mice. Thus, 3.0 g/kg BW OR showed potential for the development of functional food with antioxidant and immune-enhancement activities.
INTRODUCTION
Reactive oxygen species (ROS) generated inside cells as metabolism products play a dual role as harmful and beneficial species. Low/moderate ROS concentrations participate in some physiological processes, including signal transduction pathway, mitogenic response induction, cell proliferation, and differentiation in body (Valko et al., 2007) . However, when bodies are influenced by harmful environmental stress, such as X-ray irradiation, smoking and alcohol overconsumption, and long-term exposure to heavy metals or organic pollutants, the balance between ROS generation and elimination can be destroyed to produce excess ROS, thereby inducing oxidative stress (Srivastava et al., 2017) . ROS-induced oxidative stress can damage DNA, proteins, and lipids (Martinez-Useros et al., 2017) , leading to cellular death and aging (Lee, Wei, 2001) , and several diseases, including cancer (Nicolussi et al., 2017 ), Alzheimer's disease, Parkinson's disease, diabetes (Umeno, Biju, Yoshida, 2017) , inflammation (Pillon Barcelos et al., 2017) , and chronic obstructive pulmonary disease .
Endogenous enzyme-based antioxidants and metabolites, such as superoxide dismutase (SOD), glutathione peroxidase, catalases, and glutathione (GSH), can quench excess ROS to reduce the damaging effects of free radicals. Unfortunately, the concentrations of these endogenous antioxidants are usually lower than the level required to scavenge free radicals; thus, exogenous antioxidant supplement may be required in these cases (Szuroczki, Koprivnikar, Baker, 2016) . Antioxidants are also involved in their effects on immune enhancement (Knight, 2000) . The main components of immune cell membrane are polyunsaturated fatty acids (PUFAs), which are sensitive to free radicals; therefore, antioxidants in immune cells can protect PUFAs against oxidative damages, thereby maintaining the integrity and function of membrane lipids, nucleic acids, and cellular proteins (Amir Aslani, Ghobadi, 2016) . For example, antioxidant vitamins, such as vitamins C and E, coupled with carotenoids can increase the number of circulating lymphocytes to increase the rejection response to xenobiotics and evoke the immune system (Bendich, 1996; Szuroczki, Koprivnikar, Baker, 2016) .
The Chinese brown frog Rana chensinensis is one of the well-known economic animals farmed in northeast China. Its natural population was listed as the national key-protected wild medicinal material by the Chinese government in 1987. The economic value of R. chensinensis mainly depends on its dried oviduct, Oviductus ranae (OR), which was first recorded in the Compendium of Materia Medica in the Ming Dynasty. According to traditional Chinese medicine, OR can nourish the kidney, strengthen the essence, and moisten the lung to nourish yin. Since 1985, OR has been listed in Chinese Pharmacopeia for the treatment of various ailments, including debilitation, night sweat, neurasthenia, insomnia, and climacteric syndrome . Modern pharmacological studies have revealed that OR exerts several activities (Ling et al., 2017; Sui et al., 2016; Zhang et al., 2017) , such as antifatigue, reproductive protection, anti-osteoporosis, anti-apoptosis, and estrogenlike effects. Ling et al. (2017) found that OR-containing serum can protect rat ovarian granulosa cells from H 2 O 2 -induced apoptosis by decreasing ROS production and improving the potential of mitochondrial membrane via mitogen-activated protein kinase signaling pathway activation and downregulation of the negative regulators of proliferation. OR is rich in proteins; in some cases, its protein content exceeds 50% (Huang et al., 2014) . Studies associated with proteins from OR (POR) have indicated that POR hydrolysate can enhance immunity by enhancing the phagocytosis of macrophages, by increasing interleukin (IL)-1β, IL-6, tumor necrosis factor-α, and nitric oxide levels, and by upregulating the mRNA and protein expression of nitric oxide synthase (Huang et al., 2014) . Thus far, information regarding the antioxidant and immunomodulatory activities of OR in experimental animals in the same dose is limited.
The genus OR has been mainly explored because it is an essential traditional animal-based medicine with diverse pharmacological effects. The chemical composition, amino acids, and toxicity of OR have been investigated . OR also contains 56.87% ± 1.35% proteins, 4.91% ± 0.17% fats, 9.39% ± 0.35% moisture, 5.54% ± 0.29% ash, and 17 amino acids, with threonine having the highest content of 66.35 mg/g (Table I ). In addition, OR is highly safe with a median lethal dose (LD 50 ) higher than 20 g/kg BW in mice. Considering the clinical indications of OR related to oxidative stress (Saeidnia, Abdollahi, 2013) , we conducted this research to confirm its effects on the status of oxidative stress and to assess its functions on the immune system in the same dose. (Jilin, Jilin, China) . Before the experiment was performed, OR was ground into powder and sieved to 100 mesh.
MATERIAL AND METHODS

Material
Reagent kits for the determination of malon dialdehyde (MDA, thibabituric acid method), total superoxide dismutase (T-SOD, hydroxylamine method), GSH, Experimental animals were placed in polypropylene cages and allowed free access to food and water. The feeding conditions were temperature 20 ± 2 °C, relative humidity 60 ± 10%, 12 h-light/dark cycle, and ventilation frequency of ≥10 times/h. The animals were accustomed to housing conditions at least 1 week before the experiment. Animal experiments were conducted in compliance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals (NIH Publications No. 8023, revised 1978) and approved by the Animal Care and Welfare Committee of Jilin Institute of Chemical Technology.
Antioxidant evaluation in mice
In accordance with a previous work (Peng et al., 2015) with minor modifications, an ethanol-induced oxidative stress mouse model was used to assess the antioxidant activity of OR. The minimal treatment dose of OR was selected in accordance with the reported literature (Ling et al., 2017) , which showed that 0.09 g/kg BW in the rats was taken as the low dose for the evaluation of the use of OR in oxidative stress-induced apoptosis. Thus, 0.1 g/kg BW in mice was chosen as the minimal dose in the present study, and 1.0 (10-fold) and 3.0 g/kg BW (30-fold) were designed as the two other treated doses for the preliminary test (data not shown). Four antioxidant biomarkers, namely, MDA (lipid peroxidation product), T-SOD (antioxidase), GSH (endogenous antioxidant), and PCO (protein oxidation product), were selected.
The mice were randomly divided into five groups (10 mice per group), namely, normal control (NC), model control (MC), and three OR-treated groups. Before the experiment was performed, the OR powder was soaked in distilled water for 12 h and homogenized using a tissue homogenizer. The mice in the OR-treated groups were administered with OR suspension (2 mL/100 g BW) by oral gavage once a day at doses of 0.1, 1.0, and 3.0 g/kg BW for 30 consecutive days. The mice in the NC group were orally treated with an equal amount of distilled water.
On the last day, after fasting for 12 h, the mice except the NC group were orally administered with 50% (v/v) ethanol solution to induce oxidative stress in a dose of 12 mL/kg BW. After 6 h, the animals were anesthetized with pentobarbital sodium (50 mg/kg BW, intraperitoneally), and the blood samples were collected from an orbit to prepare the serum to determine T-SOD and MDA through centrifugation at 4000 rpm at 4 °C for 10 min. The mice were euthanized with carbon dioxide, and the livers were dissected immediately, washed, homogenized in normal saline, and centrifuged at 4000 rpm at 4 °C for 10 min to obtain the supernatant for GSH and PCO quantification. MDA, T-SOD, GSH, and PCO were determined in accordance with the methods described in the kits' instructions.
Immunomodulatory evaluation in mice
The immune-enhancement function of OR in the mice was evaluated in the same dose range (0.1, 1.0, and 3.0 g/kg BW), and several tests regarding immunomodulatory evaluation were conducted (Fang et al., 2014; Pan et al., 2016; Pan et al., 2013; Xu et al., 2008; Yu et al., 2016) .
The mice were randomly divided into five groups (I-V). In each group, the mice were separated into four subgroups (10 mice per subgroup), that is, NC and three different OR-treated subgroups. Group I was used to determine immune organ indices, hemolytic activity, and antibody-producing cells; Group II was utilized to conduct a carbon clearance test; Group III was set for lymphocyte proliferation and NK cell activity; Group IV was assigned for delayed-type hypersensitivity response; and Group V was established for peritoneal macrophages phagocytosing CRBC. The mice in the OR-treated groups were orally administered at 0.1, 1.0, and 3.0 g/kg BW once daily for 30 consecutive days, and the mice in the NC groups were treated with an equal amount of distilled water.
Hemolytic activity, antibody-producing cells, and immune organ indices
On the 25th day, the mice in Group I were immunized by intraperitoneally injecting 0.2 mL of SRBC (10%, v/v) once a day. On the 30th day, the mice were weighed and anesthetized with pentobarbital sodium (50 mg/kg BW, intraperitoneally). Their blood samples were collected from the orbit, stored at 4 °C for 1 h, and centrifuged at 4000 rpm for 10 min. The resulting supernatant was diluted 400-fold with normal saline, and 1 mL of the diluted serum was mixed with 0.5 mL of SRBC (10%, v/v) and 1.0 mL of guinea pig serum (8%, v/v) at 37 °C for 30 min. The mixtures were centrifuged at 2000 rpm for 10 min, and 1.0 mL of supernatant was mixed with 3.0 mL of Drabkin's reagent. Similarly, 0.25 mL of SRBC and 3.75 mL of Drabkin's solution were mixed for 10 min as a positive control. The optical density (OD) at 540 nm was measured, and the half value of hemolysis (HC 50 ) was calculated as follows: HC 50 = (OD sample /OD positive control ) × 400.
After blood extraction, the mice were euthanized with carbon dioxide, and the spleen and thymus were excised and weighed immediately. The immune organ indices were expressed as follows: thymus or spleen index (mg/g) = thymus or spleen weight (mg)/body weight (g). The collected spleens were pooled in Hank's solution and homogenized to prepare cell suspensions, which were subsequently resuspended in 5 mL of RPMI-1640 medium and adjusted to a concentration of 5 × 10 6 cells/ mL. The medium containing agarose (1%, w/v) was kept at 45-50 °C, mixed with an equal amount of Hank's solution (pH 7.2-7.4), and split into test tubes (0.5 mL per tube). Afterward, 20 μL of splenocyte suspensions and 50 μL of SRBC were added to the test tubes, mixed, and poured onto a glass slide containing an agarose layer. After the blood clotted, the glass slide was incubated at 37 °C for 1.5 h, guinea pig serum (8%, v/v) was poured into the frame of glass slide, and continuously incubated at 37 °C for another 1.5 h. The number of plaque-forming cells (PFC) was counted.
Carbon clearance test
On the last day, the mice in Group II were weighed and treated with 0.5 mL of diluted Indian ink (1: 4 diluted with normal saline) through tail intravenous injection. Afterward, 20 μL of blood samples was collected from the angular vein plexus at 2 min (t 1 ) and 10 min (t 2 ). The blood samples were mixed with 2.0 mL of sodium carbonate solution (0.1%, w/v), and the OD values (OD 1 for 2 min and OD 2 for 10 min) were measured at 600 nm. The mice were euthanized with carbon dioxide, and the livers and spleens were immediately harvested and weighed. The phagocytic index (α) and the carbon clearance index (k) were calculated on the basis of the following formula:
where A is the body weight, B is the liver weight, and C is the spleen weight.
Lymphocyte proliferation and NK cell activity assays
On the 30th day, the mice in Group III were euthanized with carbon dioxide. The spleens were immediately removed and homogenized in Hank's solution to prepare single-cell suspensions, which were resuspended in RPMI 1640 complete medium (RPMI 1640 medium containing 10% calf serum, 100 U/mL benzylpenicillin, and 100 U/mL streptomycin) and adjusted to a concentration of 3 × 10 6 cells/mL. In 24-well plates, splenocyte suspensions from each mouse were equally divided into two wells (1 mL per well) and cultured with 7.5 μg/mL of ConA as a stimulated sample or without ConA as a nonstimulated sample. The sample was incubated in an atmosphere with 5% CO 2 at 37 °C for 68 h, 0.7 mL of supernatant was removed from each well. Afterward, 0.7 mL of RPMI-1640 medium without calf serum and 50 μL of MTT (5 mg/mL) were added to each well for another 4 h of incubation. Finally, 1 mL of acidic isopropanol was transferred into each well and mixed to dissolve the purple formazan crystals. The OD values at 570 nm were measured, and the lymphocyte proliferation of OR was evaluated on the basis of the following formula:
OD difference = OD stimulated sample − OD nonstimulated sample Splenocytes (effector cells) were prepared in accordance with the above mentioned method to evaluate the splenic NK cell activity, and lactate dehydrogenase (LDH)-releasing method was applied to examine the NK cell activity by using YAC-1 cells as target cells. Before the experiment was performed, the YAC-1 cell suspensions were adjusted to a concentration of 4 × 10 5 cells/mL, and the splenocytes were adjusted to a concentration of 2 × 10 7 cells/mL. Subsequently, 100 μL of splenocyte suspensions and 100 μL of YAC-1 cell suspensions were added to one well of a 96-well plate as the experimental LDH release of the effector/target cell coculture group (tested group). Then, 100 μL of YAC-1 cell suspensions and 100 μL of RPMI-1640 medium were mixed as the spontaneous LDH release control group of the target cells (negative control). Afterward, 100 μL of YAC-1 cell suspensions and 100 μL of NP40 (1%, w/v) were mixed as the total LDH release control group of the target cells (positive control). The plates were incubated in an atmosphere with 5% CO 2 at 37 °C for 4 h and centrifuged at 1500 rpm for 5 min, and 100 μL of supernatant in each well was collected in another 96-well plate for the activity test. Then, 100 μL of LDH substrate solution (5 × 10 −2 mol/L lithium lactate, 6.6 × 10 −4 mol/L INT, 2.8 × 10 −4 mol/L PMS, and 1.3 × 10 −3 mol/L NAD) was added to each well and mixed at room temperature for 10 min. The reaction was quenched by adding 30 μL of 1 mol/L hydrochloric acid. The OD value at 490 nm was determined, and the NK cell activity was calculated by the following equation: NK cell activity (%) = (OD tested group − OD negative control )/(OD positive control − OD negative control ) × 100.
Delayed-type hypersensitivity response
On the 25th day, the mice in Group IV were immunized with 0.2 mL of SRBC (2%, v/v) through intraperitoneal injection once daily. After 4 days (day 29), the thickness of each mouse's left hind voix pedis was measured, and 20 μL of SRBC (20%, v/v) was injected into the left hind voix pedis of each mouse. After 24 h (day 30), the thickness of the left hind voix pedis was measured again. The swelling of voix pedis was expressed as the difference in the thickness of each mouse's left hind voix pedis between days 29 and 30.
Peritoneal macrophages phagocytosing CRBC
On the 30th day, the mice in Group V were injected with 1 mL of CRBC (20%, v/v) via the abdominal cavity. After 30 min, the mice were euthanized with carbon dioxide, injected with 2 mL of Hanks' solution via the abdominal cavity, and massaged on the abdomen twenty times to fully leach out the peritoneal macrophage. The abdominal cavities of the mice were cut open with a small incision, and 1 mL of peritoneal fluid was transferred onto glass slides. The glass slides were incubated at 37 °C for 20 min, rinsed with normal saline, dried, fixed with methanol, and stained with Giemsa stain (4%, v/v). Under a microscope, 100 macrophages per mouse were examined to count the macrophages phagocytosing CRBC. The phagocytic rate was calculated using the following formula: the phagocytic rate (%) = the number of macrophage phagocytosing CRBC/the number of counting macrophages × 100, and the phagocytosis index = the total number of phagocytosed CRBC/the number of counting macrophages.
Statistical analysis
Data were represented as mean ± or + SD (standard deviation). One-way ANOVA was conducted using SPSS19.0 (SPSS Inc., Chicago, USA). When variance was homogeneous, the least significance difference was applied to estimate the differences between groups. When variance was heterogeneous, Tamhane's test was adopted. P < 0.05 was considered significant.
RESULTS AND DISCUSSION
Antioxidant evaluation in mice
Levels or activities of some endogenous substances and enzymes can directly reflect the real status of oxidative stress in the body. Excess free radicals in vivo easily react with PUFAs to produce lipid peroxides, and MDA is the most common product of lipid peroxidation, which is in proportion to the degree of oxidative damage (Esterbauer, Schaur, Zollner, 1991) . By contrast, PCO, an irreversible form of protein modification, has been reported to be more stable than MDA. Under the condition of oxidative stress, PCO is usually formed earlier than other oxidative damage-related biomarkers (Weber, Davies, Grune, 2015) . Superoxide dismutases (SODs) are an antioxidase that scavenge superoxides by converting a highly reactive superoxide radical to a relatively lower hydrogen peroxide through dismutation. The body has three SOD isozymes (SOD-1, SOD-2, and SOD-3), which catalyze the same reaction but exhibit different enzymatic properties and localizations (Hu, Klann, and Thiels, 2007) . GSH is a cysteine-based endogenous antioxidant, which widely participates in the detoxification of xenobiotic substances, coupled with free radical antioxidation, because of the existence of a thiol group (Bray, Taylor, 1993) . The effects of OR on several oxidative stress-related biomarkers in the present investigation are shown in Figure 1 . Significant differences (P < 0.01) in MDA, T-SOD, GSH, and PCO were found in MC compared with those in NC, suggesting that an ethanol-induced oxidative stress mouse model is well established.Significant differences (P < 0.05, P < 0.01) in MDA and GSH in all of the OR-treated groups were noted compared with those in MC, and significant differences (P < 0.05, P < 0.01) in T-SOD and PCO were found at 1.0 and 3.0 g/kg BW of the OR-treated groups. The effects increased as the dose increased, especially T-SOD, GSH, and PCO, and dose-dependent manners (P < 0.05, P < 0.01) were oberved in those cases. These results indicated that OR elicited an antioxidant activity against oxidative stress induced by ethanol in the mice by decreasing MDA and PCO and by increasing T-SOD and GSH. The 3.0 g/kg BW in the mice was a highly potential dose candidate for the development of OR as an antioxidant functional food.
The in vivo antioxidant activity of OR may be contributed by the absorbed digestive products of protein because the protein content in OR is 56.87% ± 1.35%. The main digestive products of proteins are amino acids and peptides; their amino acid types and compositions are closely related to antioxidant activities . Previous studies manifested that some amino acids, including threonine, cysteine, methionine, tryptophan, tyrosine, histidine, phenylalanine, glutamic acid, aspartic acid, and lysine, can act as antioxidants (Habte-Tsion et al., 2016; Oh et al., 2016; Saiga, Tanabe, Nishimura, 2003) . Table I shows that eight antioxidant amino acids are present in OR: aspartic acid (46.15 mg/g), threonine (66.35 mg/g), glutamic acid (48.37 mg/g), methionine (2.96 mg/g), tyrosine (7.99 mg/g), phenylalanine (18.15 mg/g), lysine (30.59 mg/g), and histidine (7.18 mg/g), which account for 51.68% of the total amount of amino acids in OR. The essential amino acids in OR (Table I ) may also exert their beneficial effects against oxidative stress (D' Antona et al., 2016; Eisler, Fröhlich, and Heidenreich, 2004) . 
Immunomodulatory evaluation in mice
ROS-based free radicals are important in innate and adaptive immune responses (Knight, 2000) . They may influence adaptive immunity through the regulation of T cell activation, and the exposure of T-lymphocytes to normal physiological concentrations of ROS not only circumvents the requirement for signaling initiation but also enlarges signaling cascades induced by weak receptor stimulation (Hehner et al., 2000) . However, when an imbalance between prooxidant and antioxidant systems occurs, the activated T cells can be killed by excess ROS (Hildeman et al., 2003; Devadas et al., 2002) , suggesting that the inhibition of oxidative stress can increase the quantity of activated T cells, subsequently enhancing immunity. Thus, in this work, followed by antioxidant evaluation, the immunomodulatory activities of OR were assessed in the same dose range.
Effects of OR on immune organ indices, lymphocyte proliferation, delayed-type hypersensitivity response, hemolytic activity, and antibody-producing cells
Adaptive immune responses in the body include defenses against infection or immunization, which consist of cellular and humoral immunities. The antibody response evoked by immunization with a foreign antigen is an important assay of immune function (LeMaoult, Szabo, and Weksler, 1997) . After the mice were immunized with SRBC, B-lymphocytes secreted hemolysin, and the content of hemolysin in the serum could be used to estimate the status of humoral immune function. In addition to releasing various cytokines, T-lymphocytes could also directly eliminate the target cells. Thus, the proliferation of T-lymphocytes is essential for the activation cascade of cellular and humoral immune responses (Yu et al., 2016) . Table II shows that the OR treatment increased the half value of hemolysis (HC 50 , hemolytic activity), the number of PFC (antibody-producing cells), lymphocyte proliferation, and swelling degree of voix pedis (delayed-type hypersensitivity response) in the mice as the dose increased. Significant differences (P < 0.05) in HC 50 and PFC were found in 3.0 g/ kg BW of the OR-treated group, and significant differences (P < 0.05, P < 0.01) in the swelling degree of voix pedis were observed in 1.0 and 3.0 g/kg BW of the OR-treated groups compared with those in NC. However, no significant differences in lymphocyte proliferation were noted. For immune organ weights, OR slightly affected the thymus and spleen indices compared with those of NC. This observation is consistent with the results of previous work , which demonstrated that OR treatment has no effects on the relative organ weights of rats in a repeated dose in a 28-day toxicity study.
These results indicated that OR might enhance cellular and humoral immunities by increasing the hemolytic activity, antibody-producing cells, and delayedtype hypersensitivity response in the mice. For lymphocyte proliferation, an increase in dose should be further investigated to confirm the effects of OR on lymphocyte proliferation.
Effects of OR on mononuclear phagocytic function
The capacity of the body to fight against infection is attributed not only to adaptive immune responses to specific antigens mediated by T and B lymphocytes but also to innate immune responses (Xu et al., 2008) . The mononuclear phagocyte system (MPS) is a family of cells consisting of bone marrow progenitors, blood monocytes, and tissue macrophages. Among them, monocytes and macrophages originate from bone marrow progenitors, and macrophages are differentiated from monocytes. The main immune function of monocytes and macrophages resides in their phagocytosis of pathogenic organisms 2.98±0.06 4.86±0.18 Data denoted were means ± SD (n = 10). Different symbols indicate statistically significant differences, * P < 0.05 and ** P < 0.01 compared with NC group. HC 50 , the half value of hemolysis; PFC, the number of plague forming cells; OD, the value of optical density; OR, Oviductus ranae; NC, normal control. (Chen et al., 2010; Hume, 2006) . Table III shows that OR in doses of 1.0 and 3.0 g/kg BW significantly enhanced the phagocytic capacities of mononuclear macrophages in carbon clearance compared with those in NC (P < 0.05, P < 0.01). By contrast, OR slightly affected the phagocytosis of peritoneal macrophages phagocytosing CRBC, and no statistically significant differences were observed compared with those in NC.
These results indicated that OR might chiefly enhance the phagocytosis of liver macrophages instead of peritoneal macrophages and elicit more effects on Kupffer cells than on other macrophages because ink is mainly cleared by liver macrophages, which mainly consist of Kupffer cells (Xu et al., 2008) .
Effects of OR on NK cell activity
In addition to MPS, NK cells, a kind of granular lymphocytes derived from bone marrow, act as major components of innate immunity. They mainly reside in spleen and spontaneously possess capabilities to kill pathogen-infected and tumor cells (Yu et al., 2016) . Figure 2 shows that OR treatment enhanced the NK cell activity as the dose increased, and significant differences (P < 0.05) were observed between NC and 3.0 g/kg BW of the OR-treated groups.
In the same dose range (0.1, 1.0, and 3.0 g/kg BW) of antioxidant evaluation, OR can enhance delayed-type hypersensitivity response, hemolytic activity, antibodyproducing cells, liver macrophage phagocytosis, and NK cell activity, but OR slightly affected lymphocyte proliferation, peritoneal macrophage phagocytosis, and immune organ indices. In mice, 3.0 g/kg BW is also a dose candidate for the development of OR as an immuneenhancement functional food. The immunomodulatory capacities of OR can also be attributed to its absorbed amino acids. Amino acids play an important in immune responses by regulating the activation of lymphocytes, NK cells, and macrophages; the production of cytokines and antibodies; and the state of cellular redox, lymphocyte proliferation, and gene expression (Li et al., 2007) .
CONCLUSION
In conclusion, OR exerts antioxidant and immunomodulatory activities in mice in the same dose range. It can decrease MDA and PCO, increase T-SOD and GSH, and enhance liver macrophage phagocytosis, delayed-type hypersensitivity response, hemolytic activity, antibodyproducing cells, and NK cell activity. Conversely, OR slightly affects lymphocyte proliferation, peritoneal macrophage phagocytosis, and immune organ indices. Our results suggest that 3.0 g/kg BW is a promising dose candidate for the development of OR as a functional food with antioxidant and immune-enhancement functions.
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FIGURE 2 -Effects of OR on NK cell activity. Data are means ± SD (n = 10). The symbol (*) indicates significant differences. * P < 0.05 compared with the NC group. NK cells, natural killer cells; OR, Oviductus ranae; NC, normal control.
